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ABSTRACT 
Obesity is a worldwide problem that has reached epidemic proportions both in developed and 
developing countries. The excessive accumulation of fat poses a risk to health since it favours 
the development of metabolic alterations including insulin resistance and tissue inflammation, 
which further contribute to the progress of the complex pathological scenario observed in the 
obese. In this review we put together the different outcomes of fat accumulation and insulin 
resistance in the main insulin-responsive tissues, and discuss the role of some of the key 
molecular routes that control disease progression both in an organ-specific and also in a more 
systemic manner. Particularly, we focus on the importance of studying the integrated 
regulation of different organs and pathways that contribute to the global pathophysiology of 
this condition with a specific emphasis on the role of emerging key molecular nodes such as 
the G protein-coupled receptor kinase 2 (GRK2) signalling hub. 
 
INTRODUCTION 
Obesity is a pathological condition in which there is an excessive accumulation of body 
fat that contributes to a myriad of pathological effects. Over the last decade, the prevalence of 
obesity has reached epidemic proportions. The onset of obesity is linked to an imbalance 
between energy intake and energy expenditure (EE) (Weiser, 1997). However, given the 
complex nature of the regulation of fat mass content and the multiple compensatory 
mechanisms involved, counteracting obesity stands as a difficult challenge. Of note, visceral 
obesity is recognized as a key risk factor for the development of hypertension, dyslipidaemia, 
impaired glucose tolerance and insulin resistance (IR) (Kopelman, 2007). Insulin signalling 
regulates glucose and lipid metabolism as well as energy homeostasis by acting on different 
insulin-target tissues including liver, skeletal muscle, adipose tissue, heart and vessels (Figure 
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1). Therefore, the consequences of IR underlie the development of a wide variety of metabolic 
disorders, including cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and 
type 2 diabetes (T2D). Considering the multi-organ effects of insulin and the integration of 
the effects of obesity and IR in the different tissues (Figure 1), it is crucial to understand how 
this physiopathological network operates in order to design suitable therapeutic approaches 
for the treatment of these disorders. 
The functional defects associated to IR partially arise from impaired insulin signalling 
through the PI3K/AKT axis in the different insulin-target tissues. In this regard, insulin exerts 
its actions via complex signalling networks with positive and negative modulators acting at 
different stages of the transduction cascade, which tightly control the biological response to 
this messenger. Alterations in any of these modulators may lead to the development of IR. 
These alterations include changes in protein functionality as well as mutations or aberrant 
posttranslational modifications in the components of the insulin signalling pathway 
(Biddinger and Kahn, 2006, Gesta, 2006).  
 
Insulin signalling and IR 
Insulin binding stimulates tyrosine auto-phosphorylation in the insulin receptor β subunits 
which activates its kinase activity and recruits and phosphorylates members of a family of 
adaptor proteins called insulin receptor substrates 1–6 (IRS1–6) (reviewed in (Taniguchi, 
2006)). IRS proteins act as scaffolds coupling IR stimulation to downstream effectors, 
recruiting and activating various SH2 domain–containing proteins, including the 
phosphatidylinositol 3-kinase (PI3K). The activation of PI3K produces PI3,4P2 and 
PI3,4,5P3, which recruit PDK1 and AKT to the plasma membrane. AKT is activated via 
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phosphorylation at T308 by PDK1 and at S473 by mTOR in complex with Rictor, this 
complex known as mTORC2 and also termed PDK2. AKT phosphorylates many cellular 
proteins, allowing the metabolic and transcriptional reprogramming of the cell (White, 2003) 
(Figure 2). In many cases AKT substrates directly controlling metabolic steps have been 
identified, such as glycogen synthase kinase 3 (GSK3) (Cross, 1995), the transcription factor 
Forkhead box O (FoxO) (Biggs, 1999), the phosphodiesterase PDE3B (Kitamura, 1999) or 
TBC1D4/AS160, a Rab GTPase-activating protein (GAP) (Kane, 2002), which plays an 
important role in insulin-stimulated translocation to the plasma membrane of the glucose 
transporter GLUT4. Additionally, AKT activation can activate mTOR in complex with 
Raptor, also known as mTORC1, which in turn activates S6K1 promoting the serine 
phosphorylation of IRS1 and reducing its stability in an auto-regulatory negative feedback 
loop (Harrington, 2005). Indeed, in contrast to tyrosine phosphorylation, the multi-site 
serine/threonine phosphorylation of IRS has classically been described to inhibit the 
interaction between its PTB domain and the phosphorylated receptor causing their 
dissociation and decreasing tyrosine phosphorylation (reviewed in (Copps and White, 2012)), 
although some studies have demonstrated that certain phosphorylations on serine residues 
have a positive effect on insulin signalling (Copps, 2010). 
IR is a pathological condition in which cells fail to respond to the actions of insulin. Given 
that IR is a complex metabolic disorder that challenges a key signalling pathway, defining the 
precise mechanisms of IR in peripheral tissues is difficult while vital for the development of 
new and more effective therapies for T2D. In this regard, several studies have demonstrated 
that hyperinsulinemia, hyperlipidaemia, mitochondrial dysfunction and oxidative stress routes 
lead to attenuated insulin signalling and decreased cellular responsiveness to insulin. 
Moreover, accumulation of lipid metabolites, activation of the unfolded protein response 
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(UPR) and activation of proinflammatory signalling cascades have also been related to the 
pathogenesis of this disorder (reviewed in (Samuel and Shulman, 2012)).   
Inflammation and IR  
Remarkably, obesity itself has been described to result in a chronic low grade inflammatory 
state, contributing to IR and metabolic dysfunction (Gregor and Hotamisligil, 2011). In fact, 
the proinflammatory cytokine TNFα has long been considered as a link between obesity and 
IR (Fernandez-Veledo, 2009a), and the roles of this cytokine in other pathologies associated 
with obesity have been examined in several experimental systems including obese mice with 
homozygous null mutations at the TNFα or TNF receptor loci (Hotamisligil, 2000, Xu, 2002). 
Several studies of this inflammatory process underlying the IR and metabolic dysfunction that 
precedes T2D, have identified components of both the innate and adaptive immune response 
as key players in regulating metabolic homeostasis (reviewed in (Brestoff and Artis, 2015)).  
TNFα and other proinflammatory cytokines activate MAP kinases (Tanti, 2012) thus 
interfering with insulin signalling. In this regard, the activity of IκB-kinase β (IKKβ) and c-
Jun NH(2)-terminal kinase (JNK), both activated by TNFα, is elevated in different tissues 
during obesity, and several studies in mice have established the importance of these kinases in 
the development of IR (Tanti, 2012, Hirosumi, 2002). Heterozygous IKKβ mice are partially 
protected against diet-induced IR (Kim, 2001a), and disruption of JNK1 function protects 
mice against obesity-induced IR (Hirosumi, 2002, Sabio and Davis, 2010). JNK2 may also 
play a role in IR, but to a lesser extent (Tuncman, 2006). At the molecular level, one 
mechanism by which these kinases impair insulin signalling is the phosphorylation of IRS 
proteins on inhibitory serine sites, either directly or indirectly (Hirosumi, 2002) (Figure 2). In 
the same line, activation of the mTORC1 node by TNFα (Gao, 2003) is known to feedback 
negatively on IRS1 via S6K, thus decreasing insulin sensitivity (Figure 2). Accordingly, mice 
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with adipose-speciﬁc knockout of the Raptor component of mTORC1 are lean, resistant to 
diet-induced obesity (Polak, 2008) and display improved glucose tolerance and 
insulin sensitivity.  
On the other hand, activation of the innate immune system in the course of obesity may also 
be mediated by metabolic signals, such as increased circulating free fatty acids (FFAs), that 
may be recognized by receptors involved in the immune response, and thereby lead to 
stimulation of inflammatory signalling cascades, including IκBα kinase/nuclear factor-κB 
(IKK/NF-κB) or endoplasmic reticulum (ER) stress-induced unfolded protein response 
(UPR), that may interfere with insulin signalling (reviewed in (Ringseis, 2015)). 
Alternative molecular mechanisms leading to IR  
While distinct signalling mechanisms specific for each tissue will be described later in 
individual paragraphs, an overview of the general mechanisms leading to IR is summarized in 
this section (and in Figure 2). 
Emerging data are pointing at endoplasmic reticulum (ER) stress as an important player in the 
pathophysiology of obesity, IR and T2D (Ozcan, 2004). In obesity the capacity of the ER is 
surpassed, thus leading to the accumulation of misfolded/unfolded proteins, a condition 
termed ER stress. Accordingly, interventions that suppress ER stress can improve diabetes 
and associated comorbidities (Ozcan, 2006). In addition, diacylglycerol (DAG)-mediated IR 
has been suggested as a further unifying hypothesis to explain the most common forms of IR 
associated with obesity and T2D. Thereby, an increase in intracellular DAG content, due to an 
imbalance between fatty acid delivery and intracellular fatty acid oxidation and storage, 
would lead to activation of new protein kinase C (PKC) isoforms that may in turn inhibit 
insulin action in liver and skeletal muscle (reviewed in (Erion and Shulman, 2010)).  
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Another mechanism potentially responsible for the insulin signalling defects found in obesity 
is the increased expression and/or activity of protein tyrosine phosphatases (PTPs), able to 
terminate signals propagated through tyrosine phosphorylation events. For instance, protein 
tyrosine phosphatase 1B (PTP1B) has been described to directly modulate insulin action in 
vitro and in vivo (Figure 2) (Goldstein, 2001). This phosphatase is increased in expression 
and/or activity in muscle and adipose tissue of obese humans and rodents (Goldstein, 2001), 
and the activation of the negative regulator of insulin signalling IKKβ/NFκB pathway 
increases its levels (Zabolotny, 2008). Accordingly, PTP1B-deficient mice show increased 
insulin sensitivity and resistance to diet-induced obesity, partly by an increased energy 
expenditure (Goldstein, 2001). Interestingly, the improved insulin sensitivity is present in 
muscle and liver but not in adipocytes (Goldstein, 2001). PTP1B inhibitors have shown 
beneficial effects to enhance insulin sensitivity, but structural homologies in the catalytic 
domain of PTP1B with other PTPs present a challenging task to achieve selectivity 
(Tamrakar, 2014).  
Along the same line, the lipid phosphatase and tensin homologue (PTEN) has also been 
widely implicated as a negative regulator of insulin/PI3K signalling (Sasaoka, 2006) (Figure 
2), apart from its role as a tumour suppressor. Several studies have shown that specific down-
regulation of PTEN in different insulin target tissues protects against insulin resistance and 
diabetes (Carracedo and Pandolfi, 2008).  On the contrary, transgenic mice overexpressing 
PTEN have also been reported to display enhanced insulin sensitivity, suggesting that 
moderate overexpression of PTEN results in improved insulin signalling and in protection 
from the damaging effects of high-fat diet (HFD). This effect, apparently paradoxical, is 
explained by the concomitant reduction in the negative feedback routes that emanate from the 
insulin signalling pathway (Ortega-Molina, 2012). 
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In the context of insulin signalling modulators, recent lines of research support the 
identification of G protein-coupled receptor kinase 2 (GRK2) as a novel and important 
negative regulator of insulin effects (reviewed in (Mayor, 2011)). GRK2 is a Ser/Thr kinase 
that has been classically named and widely studied for its role in the regulation and 
desensitization of G protein-coupled receptors (GPCRs). Besides such canonical role, recent 
data indicate that GRK2 is also able to phosphorylate a variety of non-GPCR substrates 
(Penela, 2010, Ribas, 2007). In addition, changes in GRK2 expression and activity have been 
identified in several relevant inflammatory, metabolic, cardiovascular or cancer diseases, 
suggesting that those alterations may contribute to the onset or development of these 
pathologies (Gurevich, 2012). In particular, recent data from our laboratory suggest that 
GRK2 levels play a relevant role in insulin signalling and resistance as well as in fat mass 
accretion (Garcia-Guerra, 2010). In fact, GRK2 expression levels are increased in insulin-
resistant human adipocytes, in muscle and adipose tissue from TNFα, aging or HFD-induced 
insulin-resistant murine models and also in peripheral blood cells from metabolic syndrome 
patients (Garcia-Guerra, 2010). Accordingly, GRK2 haploinsufficient (GRK2
+/-
) mice 
maintain glucose tolerance and insulin signalling in the major insulin-responsive tissues under 
different conditions of insulin resistance (Garcia-Guerra, 2010), suggesting that enhanced 
GRK2 expression impairs insulin sensitivity (Figure 2) and that a moderate decrease in GRK2 
levels/activity could be a new and feasible therapeutic strategy to tackle T2D. In keeping with 
these findings, peptide GRK2 inhibitors result in improved glucose homeostasis in different 
animal models of diabetes (Anis, 2004). Moreover, a recent work from our laboratory has 
shown that decreasing GRK2 levels in a tamoxifen-inducible mice model is not only able to 
prevent, but also to reverse a pre-established insulin-resistant and obese phenotype (Vila-
Bedmar, 2015). In this context, several tissue-specific processes seem to contribute to the 
beneficial effects of a reduction in GRK2 during a high fat feeding: improved insulin 
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signalling, enhanced lipolysis, increased expression of fatty acid oxidation and thermogenesis 
markers, and reduced hepatic steatosis and inflammation (Vila-Bedmar, 2015). At the 
molecular level, enhanced GRK2 expression appears to impair insulin-mediated AKT 
stimulation and insulin-induced glucose uptake by different mechanisms in specific tissues: 
directly interacting with IRS1 in adipocytes and myocytes (Garcia-Guerra, 2010); directly 
phosphorylating IRS1 at Ser 307 in cardiomyocytes (Ciccarelli, 2011); and by mediating 
endothelin-1-induced IR in 3T3-L1 preadipocytes via the inhibition of both Galphaq/11 and 
IRS1 pathways (Usui, 2005). Thus, the precise mechanisms modulating GRK2-mediated IR 
development in different tissues and the potential implication of phosphorylation events on 
GRK2-mediated IRS1 modulation are key issues for future research. Moreover, these findings 
are in agreement with the fact that IRS proteins represent a major node key to the 
development of IR (Copps and White, 2012).  
 
INSULIN TARGET TISSUES 
Insulin target tissues are able to function in response to insulin, given they express the insulin 
receptor and hold the appropriated intracellular enzymatic machinery able to regulate lipid 
and glucose metabolism. Under obesity or T2D conditions, these tissues are resistant to many 
of the actions of insulin. Thus, unravelling the different outcomes of obesity and IR in the 
main insulin-responsive tissues, as well as the physiopathological mechanisms involved, is 
crucial to understand the overall implications of an obese and insulin-resistant phenotype. 
In the next sections we will next summarize the most important obesity-induced alterations in 
the normal physiological functions of the different insulin target tissues, and relate these 
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alterations to the key molecular mechanisms implicated in each case, with a clear focus on the 
integration of the different mechanisms contributing to the global IR phenotype. 
 
Adipose Tissue 
The adipose tissue can be considered a multi-depot organ since it consists of several "stores" 
located in two compartments: subcutaneous and visceral (Cinti, 2005). Likewise, adipose 
depots are commonly classified following their appearance in white and brown adipose tissue, 
although some groups also refer to ‘beige’ (Ishibashi and Seale, 2010) or ‘brite’ (brown in 
white) (Petrovic, 2010) adipocytes, meaning regions of white adipose tissue containing brown 
or brown-like adipocytes.   
White adipose tissue  
White adipose tissue (WAT) has been classically considered as a mere energy store and 
generally regarded as a connective tissue lacking specific anatomy. However, accumulating 
data support the idea that WAT forms a large organ with discrete anatomy, specific vascular 
and nerve supplies, high physiological plasticity (Cinti, 2012) and important endocrine and 
homeostatic functions (Trayhurn and Beattie, 2001). Accordingly, the structural and/or 
functional changes or distribution of adipose tissue as well as its excessive fat load, rather 
than obesity itself, are the key features correlating with metabolic alterations (Primeau, 2011, 
McLaughlin, 2012).  In this regard, many researchers have reported that the intra-abdominal 
(visceral) adipose depot is a major contributor to metabolic risk, whereas the subcutaneous 
depot may have a protective role (McLaughlin, 2011). In fact, contrary to the subcutaneous 
WAT, excess of fat in visceral depots drives adipocyte hypertrophy rather than adipogenesis, 
a form of storage associated with more important metabolic alterations and inflammation 
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(McLaughlin, 2014). Nevertheless, when adipogenesis is impaired, IR and inflammation 
develop also in the subcutaneous fat, so that this depot could also participate in the 
pathogenesis of the metabolic syndrome (Weyer, 2000). Remarkably, obese mice and humans 
without adipocyte hypertrophy (hyperplastic obesity) are insulin-sensitive (Cinti, 2005, 
Hoffstedt, 2010). 
Along this line, macrophages seem to play an important role in the development of the 
metabolic disorders associated with obesity. Classical resident macrophages in WAT harbour 
a M2 or alternatively activated phenotype and produce anti-inflammatory cytokines. By 
contrast, obesity induces the recruitment of macrophages prone to M1 priming (Lumeng, 
2007) which produce pro-inflammatory cytokines that interfere with insulin signalling 
pathways (Gregor and Hotamisligil, 2011). Other immune cell populations are also modified 
in the obese such as CD8
+
 and CD4
+
TH1 lymphocytes which are increased and probably 
contribute to M1 macrophage recruitment and polarization (Nishimura, 2009, Winer, 2009). 
However, macrophages are generally considered as the effector cells contributing to 
inflammation-mediated IR, and it is macrophage infiltration what positively correlates with 
the size of adipocytes both in visceral and in subcutaneous fat (Cinti, 2005). Nevertheless, the 
number of macrophages is much higher in visceral fat, both in diet- and in genetically-
induced obesity (Strissel, 2007, Murano, 2008). This fact is in agreement with the more 
deleterious consequences of visceral obesity (compared to the subcutaneous type) on insulin 
action, and with the depot-specific effect of TNFα inducing IR through the activation of 
JNK1/2 and serine phosphorylation of IRS1 in human visceral but not in subcutaneous 
adipocytes (Fernandez-Veledo, 2009b).  
Molecular keys in WAT 
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The production of adipokines (bioactive molecules released from adipose tissues) by 
overloaded and inflamed adipose depots is altered during obesity. This deregulated adipokine 
secretion pattern further contributes to adipose inflammation and altered lipid homeostasis 
(Jung and Choi, 2014), which promotes IR and fat accumulation in ectopic tissues (DeFronzo, 
2004) leading to the stimulation of stress-induced kinases such as JNK and IKK-β. Moreover, 
activation of these kinases within the adipose tissue further contributes to the production of 
pro-inflammatory cytokines, such as IL-6, that lead to the development of IR in other tissues, 
including the liver (Sabio, 2008), and also in vitro in human myocytes (Fernandez-Veledo, 
2008). FFAs also exacerbate pro-inflammatory cytokine secretion from M1 macrophages 
through activation of toll like receptors (TLRs). Interestingly, stress kinases may also be 
directly induced by FFA or endotoxemia through activation of TLR2 and 4 (Shoelson, 2007), 
thus providing an additional mechanism for the direct induction of IR and inflammation by 
dietary and gut-derived products. On the contrary, exercise reduces TLR4 expression, 
suppressing M1 macrophage infiltration in adipose tissue and/or promoting phenotypic 
switching from pro-inflammatory M1 to anti-inflammatory M2 macrophages (Ringseis, 
2015). Along the same line, increasing fatty acid oxidation in adipocytes and macrophages 
has been suggested to decrease TG content and inflammation in adipocytes and reduce ER 
stress and oxidative damage in macrophages as well as improving insulin sensitivity 
(Malandrino, 2015). 
Importantly, insulin is a critical regulator of several aspects of adipocyte biology. This 
hormone promotes adipocyte triglyceride storage by several mechanisms, including 
promoting adipocyte differentiation, and stimulating glucose uptake and triglyceride synthesis 
while inhibiting lipolysis. Insulin also enhances the uptake of FA from circulating 
lipoproteins by stimulating lipoprotein lipase (LPL) activity in WAT. Thus, maintaining the 
integrity of insulin signalling in adipocytes is crucial for the proper functioning of this tissue. 
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Contrary to skeletal muscle, during obesity and T2D the expression of the glucose transporter 
GLUT4 is selectively decreased in adipocytes, and adipose-specific knockout or 
overexpression of GLUT4 alters systemic insulin sensitivity (Abel, 2001, Yang, 2005, 
Carvalho, 2005). Another important molecule, the phosphatase PTP1B, positively correlates 
with adiposity and contributes to IR. However, the role of PTP1B specifically in adipocytes is 
unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose PTP1B 
deficiency on whole body mass and IR. Nevertheless, in a recent study using adipocyte-
specific PTP1B knockout mice, no benefit of this deletion was found in terms of glucose 
homeostasis, lipid metabolism or adipokine secretion, suggesting that PTP1B does not appear 
to be the major negative regulator of IR in adipocytes (Owen, 2012). 
On the other hand, mice lacking PTEN specifically in adipose tissue show improved systemic 
glucose tolerance and insulin sensitivity, in association with decreased fasting insulin levels, 
even when no differences in adiposity or plasma FFA were found (Kurlawalla-Martinez, 
2005). Moreover, and in contrast to the increased global insulin sensitivity of transgenic mice 
overexpressing PTEN, the WAT of these mice showed reduced levels of phosphorylated 
AKT, but also decreased levels of IRS1 in serine inhibitory sites (Ortega-Molina, 2012). 
Finally, in our laboratory we have put forward GRK2 not only as a novel regulator of insulin 
signalling in different insulin-target tissues including WAT, but also as a modulator of overall 
adiposity and fat mass accretion (reviewed in (Mayor, 2011)). In fact, GRK2 can act as an 
inhibitor of insulin-mediated glucose uptake in 3T3L1 adipocytes by interfering with Gαq/11 
(Usui, 2005), and by interacting with IRS1 independently of its kinase activity (Garcia-
Guerra, 2010). Furthermore, WAT from GRK2
+/-
 mice presents a reduced expression of 
enzymes involved in lipogenesis (Vila-Bedmar, 2012) consistent with the decreased size of 
white adipocytes in aged or HFD-fed mice compared with WT littermates (Garcia-Guerra, 
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2010). This reduced size is not related to alterations in the differentiation capacity of white 
adipocytes, since inducing GRK2 loss during a HFD also decreases epidydimal fat mass and 
adipocyte size, in association with an enhanced lipolytic capacity in WAT (Vila-Bedmar, 
2015).  
Brown adipose tissue 
Brown adipose tissue (BAT) represents a natural target for increasing energy expenditure 
(EE) since it is the main organ involved in heat production through a process known as non-
shivering adaptive thermogenesis, an energy-dissipating process key to maintaining body 
temperature. This process depends on the specific expression of the uncoupling protein 
(UCP)1 in the mitochondrial inner membrane of brown adipocytes, which allows to dissipate 
the excess of energy in the form of heat (reviewed in (Cannon and Nedergaard, 2004)). 
Therefore, although insulin regulates metabolism in both brown and white adipocytes, the role 
of both tissues in energy storage and utilization is quite different. Unlike WAT, BAT 
accumulates lipids not as a store for excess of energy but as a source of FA to be oxidized in 
mitochondria when thermogenesis is activated to produce heat at the expense of coupled ATP 
production, although an increase in the uncoupling machinery of brown adipocytes has also 
been described to be followed by an enhancement of proteins involved in ATP synthesis 
(Guillen, 2013). BAT was classically considered of metabolic significance only in small 
mammals and human newborns, since it was thought to disappear rapidly after birth in 
humans. However, several pieces of evidence have put forward the role of this tissue in the 
regulation of energy balance in humans (reviewed in (Vila-Bedmar and Fernandez-Veledo, 
2011, Cypess and Kahn, 2010)).  As a result, much interest has focused on BAT as a target for 
pharmacotherapy of obesity-associated disorders. In fact, alterations in this tissue have been 
related to adiposity control, IR and T2D (Lowell, 1993, Feldmann, 2009). 
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Given the role of BAT as a sink for draining and oxidation of glucose and triglycerides from 
blood, promotion of BAT development/activity or even remodelling of WAT depots in order 
to promote browning of this tissue offers the possibility of increasing EE, contributing to the 
reduction of body weight and the improvement of glucose tolerance. In keeping with this 
notion, the inherent plasticity of the adipose organ offers the possibility to manipulate this 
tissue, pointing at the enhancement of BAT activity as an important therapeutic strategy in the 
protection against obesity and metabolic syndrome. In fact, animals with higher amount of 
BAT are more resistant to obesity and T2D (Kopecky, 1995, Collins, 2004, Almind, 2007) 
whereas, animals without functional BAT are prone to these conditions (Lowell, 1993, 
Feldmann, 2009). Most interestingly, these observations are also valid for humans (Vila-
Bedmar and Fernandez-Veledo, 2011, Cypess and Kahn, 2010).  
Molecular keys in BAT 
While sympathetic innervation of BAT plays an essential role in its thermogenic function, 
several studies in vitro and in vivo have revealed that brown adipocytes are also target cells 
for insulin action, since insulin stimulation increases glucose uptake and GLUT4 translocation 
to the plasma membrane in foetal brown adipocytes (Lorenzo, 2002, Valverde, 2005). 
Interestingly, IR in BAT has been associated with impaired thermogenesis in obese mutant 
rodents (Mercer and Trayhurn, 1984). However, the mechanism by which insulin affects 
glucose transport in brown fat appears to be unrelated to the activation of thermogenesis. In 
fact, transgenic mice moderately overexpressing PTEN present BAT hyperactivity mediated 
by the inhibition of PI3K/AKT/Foxo signalling pathway and associated with increased EE 
and with lower adiposity and body weight. These effects run in parallel to a number of 
systemic beneficial consequences, including improved insulin sensitivity and protection from 
HFD-induced IR and steatosis (Ortega-Molina, 2012). Additionally, in the absence of insulin, 
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physiological concentrations of norepinephrine stimulate glucose transport in brown 
adipocytes via β-adrenergic pathways (Dallner, 2006, Shimizu, 1991).  
One key mediator of IR in brown adipocytes, as described in WAT, are proinflammatory 
cytokines such as TNFα. The molecular mechanisms involved in TNFα-induced IR depend on 
de novo ceramide production (Fernandez-Veledo, 2006a) and on the activation of stress 
kinases and potential Ser-Thr phosphorylation of IRS2 (Hernandez, 2004). A significant 
enhancement of PTP1B expression and activity is observed in TNFα-treated brown 
adipocytes, and the lack of this phosphatase conferred protection against TNFα-induced 
impairment of glucose uptake or insulin signalling (Fernandez-Veledo, 2006b). Interestingly, 
this cytokine not only stimulates IR in BAT, but also acts as a negative regulator of 
adipogenic and thermogenic differentiation in brown adipocytes (Lorenzo, 2008). In addition,  
Besides glucose uptake, de novo lipid synthesis also occurs in BAT with insulin as an 
essential lipogenic regulator. In this regard, lack of IRS1 leads to IR in brown adipocytes at 
the level of thermogenic gene expression (Valverde, 2003) and lipid synthesis (Valverde, 
1999). Thus, besides its essential role in adipogenesis, IRS1 is a key molecule in mediating 
insulin-induced thermogenic gene expression in foetal brown adipocytes. 
Finally, GRK2 also appears to play an important role in BAT function and architecture, as 
well as in brown adipocyte differentiation (Vila-Bedmar, 2012). In this regard, the decreased 
weight observed in 9-month old GRK2
+/-
 mice seems to be due, at least in part, to an 
increased function of BAT in these animals. Accordingly, GRK2 hemizygous mice display 
higher EE and lower respiratory exchange ratio, which correlates with an improved 
morphology of BAT in GRK2
+/-
 adult mice (Vila-Bedmar, 2012). Along the same line, 
inducing GRK2 depletion with tamoxifen during a HFD also preserved the morphology of 
BAT that shows an enhanced lipolytic response to adrenergic stimulation. These features 
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were associated to an increased expression of thermogenic and FA oxidation markers, such as 
uncoupling protein 1 (UCP1) and carnitine palmitoyltransferase 1 (CPT1), respectively, 
which may underlie an increased capacity for fatty acid metabolism and thermogenesis in 
BAT upon GRK2 downmodulation. Accordingly, these changes would allow BAT to act as 
an efficient "metabolic sink" for the extra free fatty acids produced in WAT, thereby avoiding 
the establishment of lipotoxicity (Vila-Bedmar, 2015).  Thus, our data point toward GRK2 
inhibition as a potential tool for the enhancement of brown fat activity in addition to the 
reported function of this kinase in the regulation of insulin signalling.  
 
Liver 
The liver plays a central role in the maintenance of glucose homeostasis. During fasting, the 
liver is responsible for the synthesis of glucose from non-carbohydrate sources, in a process 
called gluconeogenesis. After feeding, when the glucose levels rise, the liver acts as a glucose 
sensor inactivating the endogenous production of glucose and storing the excess of 
monocarbohydrates as glycogen. These two processes are mainly regulated by insulin and in 
physiological conditions restore the normoglycaemia after a meal. However, in the obesity-
related diabetic or pre-diabetic state, the liver is an end-organ for the effects of IR.  Hepatic IR 
causes an increased glucose output and a decreased glucose clearance leading to sustained 
hyperglycaemia.  
One of the most important complications related to obesity-induced hepatic IR is non-
alcoholic fatty liver disease (NAFLD). NAFLD expands different stages, from simple 
steatosis to non-alcoholic steato-hepatitis (NASH) involving the development of 
inflammation, varying degrees of fibrosis and, ultimately, cirrhosis, end-stage liver failure and 
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hepatocellular carcinoma (Malaguarnera, 2009). IR promotes hepatic triglyceride 
accumulation as a result of increased peripheral adipose lipolysis and the influx of free FA 
released from dysfunctional and insulin-resistant adipocytes. IR also upregulates the levels of 
hepatic lipogenic transcription factors (Smith and Adams, 2011) causing hepatic steatosis, a 
condition often present in metabolic syndrome patients. In the steatotic liver the lipotoxicity 
caused by FA accumulation and triglyceride-derived toxic metabolites (such as DAGs and 
ceramides) triggers the activation of inflammatory pathways, reactive oxygen species (ROS)-
induced cellular dysfunction and ER stress. Altogether, these mechanisms lead to hepatic 
inflammation and worsening of hepatic IR (Smith and Adams, 2011, Malaguarnera, 2009, 
Cusi, 2012).  
 
Moreover, the liver of subjects with NAFLD might release a variety of proatherogenic, 
proinflammatory, and diabetogenic mediators (Anstee, 2013), which play an important role in 
the pathogenesis of systemic inflammation and may contribute to the development of IR and 
cardiovascular disease (Stefan and Haring, 2013). In this regard, the discovery of proteins that 
are exclusively or predominantly secreted from the liver and that directly regulate 
inflammation as well as glucose and lipid metabolism, such as fibroblast growth factor 21 
(FGF21), has boosted the investigation into this field. In parallel to the proteins released from 
adipose tissue these liver-derived proteins are known as hepatokines. Therefore, the liver not 
only functions as a target organ of inflammatory and lipolytic reactions occurring within 
dysfunctional adipose tissue, but as an inducer of systemic inflammation.  
 
Molecular keys in the liver 
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Cumulative evidence suggests that IRS2 is the major effector of the actions of insulin in 
cultured hepatocytes. A distinctive role for IRS1 and IRS2 have been suggested on the basis 
that individual knockouts of IRS1 or IRS2 have only modest effects on murine nutrient 
metabolism, while the combined knockouts result in diabetes (Dong, 2006, Haeusler and 
Accili, 2008, Gonzalez-Rodriguez, 2010). Importantly, IRS2 is highly regulated by nutrient 
signals in this tissue (Dong, 2006, Ide, 2004), and the accumulation of DAG is described to 
activate PKCϵ and/or JNK1, which can lead to impaired IRS2 tyrosine phosphorylation thus 
contributing to hepatic IR (Erion and Shulman, 2010). 
 In line with this notion, recent studies have introduced the peroxisome proliferator-activated 
receptor α (PPARα)-FGF21 hormone axis as a target for hepatic JNK-mediated IR. This study 
also demonstrates how hepatic ablation of both genes (Jnk1 and Jnk2) and not hepatic JNK1 
deficiency protects against HFD-induced IR (Vernia, 2014).  
The specific role of phosphatases that switch off the insulin signalling pathway has also been 
investigated in the liver. In this regard, reducing PTP1B levels increase hepatic insulin 
signalling, decrease expression of gluconeogenic genes, enhancing insulin-induced 
suppression of hepatic glucose production, and improves glucose tolerance (Klaman, 2000). 
Accordingly, PTP1B antisense oligonucleotides that specifically downregulate PTP1B levels 
in liver and fat enhance insulin signalling and decrease adiposity in ob/ob and db/db mice in 
parallel with a reduced expression of lipogenic genes in these tissues (Waring, 2003, Zinker, 
2002). Liver-specific PTP1B knockout led to improved systemic glucose and lipid 
homeostasis and diminished expression of lipogenic genes, also protecting against HFD-
induced ER stress response in the liver (Delibegovic, 2009). Moreover, recent studies using 
inducible liver-specific PTP1B knockdown mice have shown that PTP1B downregulation 
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reverses glucose intolerance and improves lipid homeostasis decreasing lipid deposition in the 
liver in HFD-fed obese and insulin-resistant adult mice (Owen, 2013).  
Also, a liver-specific deletion of PTEN led to increased insulin sensitivity in this tissue, 
increased skeletal muscle insulin signalling and glucose uptake and improved overall glucose 
tolerance (Stiles, 2004). Moreover, WAT depots were reduced and had characteristics of 
browning in these mice (Peyrou, 2015). This systemic insulin-sensitizing effect of a liver-
specific deletion of PTEN has been explained through the modulation of the expression of 
liver-derived circulating factors that regulate muscle insulin sensitivity and WAT 
homeostasis, such as FGF21 (Peyrou, 2015). However, PTEN expression has been reported to 
be downregulated in steatotic rat and human livers (Vinciguerra, 2008), and PTEN liver-
specific KO mice develop fatty liver through increased FA uptake and de novo lipogenesis, 
together with decreased VLDL export (Qiu, 2008), whereas transgenic mice overexpressing 
PTEN are protected against HFD-induced steatosis (Ortega-Molina, 2012). Accordingly, 
studies in hepatocytes showed that unsaturated fatty acids down-regulate PTEN levels via 
activation of a complex formed by mTOR and NFκB (Vinciguerra, 2008). The paradoxical 
results found in the liver of PTEN liver-specific KO mice suggest a bifurcation in the effects 
of PTEN on insulin signalling cascade within the liver, producing on the one hand insulin 
hypersensitivity and in the other hand inducing the accumulation of lipids in this tissue. One 
possible explanation is based on the fact that mTORC1 is required for insulin-induced 
stimulation of lipogenesis, but not for other insulin-mediated hepatic effects (Li, 2010).  
Notably, our group has shown that GRK2 levels were increased in the liver of mice fed a 
HFD (Garcia-Guerra, 2010), and decreasing GRK2 protected against HFD-induced hepatic 
insulin resistance and impaired lipid accumulation in tamoxifen-induced GRK2
-/-
 mice (Vila-
Bedmar, 2015). Along the same lines, Sprague-Dawley rats fed a HFD for two weeks 
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presented increased hepatic plasma membrane GRK2 (Charbonneau, 2007). Moreover, strong 
insulin-mediated AKT phosphorylation was detected in the liver of GRK2
+/-
 mice under 
different IR-inducing conditions (Garcia-Guerra, 2010). In vitro results in mouse liver FL83B 
cells demonstrated that GRK2 negatively regulates basal and insulin-stimulated glycogen 
synthesis via a post-IR signalling mechanism, and that GRK2 may contribute to reduced IR 
expression and function during chronic insulin exposure. Mechanistically, GRK2 seems to 
affect phosphorylation of Ser307 on IRS1, reducing insulin receptor-IRS1 interaction and thus 
insulin receptor-mediated phosphorylation of Tyr612 on IRS1 (Shahid and Hussain, 2007). A 
similar increase of IRS1 phosphorylation at Tyr612 after IGF-1 treatment was found in 
HepG2 cells with reduced GRK2 protein levels (Wei, 2013). Preliminary results from our 
laboratory also reveal a role for GRK2 in the regulation of steatohepatitis (Cruces-Sande M, 
unpublished observation), what warrants further investigation on the control of hepatic 
glucose and lipid metabolism by this kinase. 
 
Muscle 
Skeletal muscle is a critical tissue for glycaemic control since it is the quantitatively major 
site of insulin-stimulated glucose clearance in the postprandial state, accounting for 
approximately 80% of glucose disposal under insulin-stimulated conditions (DeFronzo and 
Tripathy, 2009), and it also represents the largest glycogen storage organ (almost quadrupling 
the capacity of the liver). Thus, IR and metabolic dysfunction in skeletal muscle play a major 
role in the development of the metabolic syndrome and T2D (DeFronzo and Tripathy, 2009). 
The multiple alterations in adipose tissue homeostasis occurring during obesity, including an 
altered secretion profile of adipokines as well as increased lipolysis, lead to the redistribution 
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of FFA to non-adipose tissues such as skeletal muscle (DeFronzo, 2004). As a consequence, 
increased amounts of ectopic lipid stores are found in muscle from obese patients, which have 
been reported to induce IR in skeletal muscle by directly inhibiting insulin-stimulated glucose 
transport (reviewed in (Erion and Shulman, 2010)). However, some studies suggest that the 
connection between the amount of intra-myocellular lipids and IR might not be 
straightforward, since other factors, such as lipid droplet size or training status, may also play 
a role (Eckardt, 2011). Intra-myocellular lipids provide a source for the generation of 
metabolites including DAGs and ceramides, which have been widely described to impair 
insulin signalling. Abnormal accumulation of these metabolites activates different isoforms of 
PKC, including PKCθ, as well as IKKβ and JNK kinases, reducing or even abrogating 
insulin-mediated glucose uptake. Lipid infusion studies in humans have confirmed these 
findings, although PKCβII and PKCδ, rather than PKCθ, were found to be the relevant PKC 
isoforms implicated. Additional studies with different mouse models have provided further 
insight into the mechanisms that links intracellular DAG accumulation to IR (reviewed in 
(Erion and Shulman, 2010)). Furthermore, IKKβ is able to activate NFκB, which in turn 
regulates the production of pro-inflammatory cytokines such as IL-6 (Shoelson, 2003) which 
has been reported to have a dual effect on IR in muscle: stimulating insulin actions after an 
acute IL-6 challenge, but precluding insulin signalling upon a chronic exposure (Nieto-
Vazquez, 2008).  
The accumulation of lipid metabolites may be due to an imbalance between FFA delivery and 
intracellular fatty acid oxidation and storage. Accordingly, several studies have reported that 
fatty acid oxidation is reduced in both T2D and obese insulin-resistant individuals (reviewed 
in (Kelley, 2005)), suggesting that muscular mitochondrial oxidative capacity is impaired in 
these disorders and putting forward a role for mitochondrial dysfunction as a cause of muscle 
IR. In addition, several studies performed in obese humans and rats have revealed an increase 
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in the FFA transporter CD36 at the plasma membrane of skeletal muscle cells as well as an 
enhanced transport of FFA into this tissue (Eckardt, 2011), together with a reduction in 
intracellular lipid content after specific inhibition of this transporter in myotubes obtained 
from obese patients (Aguer, 2010). Nevertheless, it is still unclear whether it is mitochondrial 
dysfunction that leads to increased intra-myocellular lipid content and IR or rather if an 
increased muscle lipid content secondary to elevated plasma FFA levels is what leads to 
mitochondrial dysfunction and IR. Despite discrepancies in the exact mechanisms, it is clear 
that an acute exposure to FFAs and excess dietary lipid intake may lead to lipid-induced IR, 
which is a major trigger for IR in muscle in obesity. Notably, recent studies have reported 
impaired regenerative capacity of skeletal muscle following injury in obese mice, pointing to 
the possibility that muscle satellite cell function is also compromised under conditions of lipid 
overload. In fact, toxic lipid metabolites would also contribute to decreased regenerative 
capacity of skeletal muscle in obese animals impairing the potential for satellite cell-mediated 
repair (reviewed in (Akhmedov and Berdeaux, 2013)). 
On the other hand, nowadays, skeletal muscle is also recognized as an endocrine organ, and 
proteins released from this tissue have been termed myokines, in analogy to adipokines 
secreted by adipose tissue. Similarly to adipokines, these recently discovered myokines are 
likewise able to mediate metabolic homeostasis, contributing to the regulation of glucose and 
fatty acid metabolism as well as modulating inflammation (reviewed in (Eckardt, 2014)). 
Molecular keys in muscle 
In morbid obesity, the expression and/or activation of some components of the insulin 
signalling cascade is altered in skeletal muscle, including IRS1 phosphorylation as well as 
PI3K activity (Goodyear, 1995), although no alterations have been reported in GLUT4 
expression levels in skeletal muscle of obese and diabetic humans (reviewed in (Shepherd and 
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Kahn, 1999)). In fact, defective glucose transport has been suggested to be due to impaired 
translocation, docking, or fusion of GLUT4-containg vesicles with the plasma membrane 
(Bogan, 2012). However, inactivation of GLUT4 in skeletal muscle leads to IR (Kim, 2001b) 
and muscle-specific overexpression of GLUT4 improves glucose disposal in animal models 
of IR (Leturque, 1996). These reports suggest that maintaining high levels of GLUT4 in 
skeletal muscle might be a potential strategy for treatment of IR. In contrast, transgenic 
overexpression of PTP1B in muscle decreased glucose uptake (Zabolotny, 2004), whereas, 
ablation of PTP1B specifically in this tissue improved systemic insulin sensitivity in mice fed 
a HFD (Delibegovic, 2007). Furthermore, PTP1B is upregulated by the proinflammatory 
cytokine TNF-α and myocytes lacking PTP1B are protected against TNF-α-induced IR 
(Nieto-Vazquez, 2007), and the lack of PTP1B has also been reported to confer protection 
against long term IL-6 treatment-induced IR in skeletal muscle in vitro and in vivo (Nieto-
Vazquez, 2008). Moreover, despite the fact that JNK1 deficiency does not enhance muscle 
glucose metabolism in lean mice (Witczak, 2006), the saturated fatty acid palmitate has been 
reported to induce PTP1B expression in skeletal muscle cells through a mechanism involving 
the activation of ceramide, JNK and NFκB pathways (MohammadTaghvaei, 2012).  
Interestingly, many chronic diseases, including obesity and IR, have been associated with 
reduced muscle mass and strength, so enhancing skeletal muscle may also offer great benefit 
in improving glucose homeostasis. In this regard, GRK2
+/-
 mice contained hypertrophied 
skeletal muscle fibres than WT littermates (Garcia-Guerra, 2014), but whether this fact 
contributes to the improved glucose homeostasis observed in hemizygous GRK2 mice is still 
unknown. In any case, tamoxifen-induced GRK2
-/-
 mice display enhanced insulin signalling 
in muscle (Vila-Bedmar, 2015), according to the suggested negative role for GRK2 in the 
regulation of insulin signalling in skeletal muscle both in cultured myocytes and in vivo in 
GRK2
+/-
 mice (Garcia-Guerra, 2010), most probably by mechanisms independent of kinase 
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activity and involving the formation of dynamic GRK2/IRS1 complexes (Garcia-Guerra, 
2010). In addition, overexpression of GRK2 in C2C12 myoblasts impairs cell differentiation, 
a process known to depend on different protein kinases including AKT (Garcia-Guerra, 
2014). 
 
Heart 
Although the heart is not a canonical metabolism-regulatory organ, IR and associated 
reductions in cardiac insulin signalling is emerging as a major factor for the development of 
heart failure. The insulin cascade is crucial to maintaining cardiac functionality since the heart 
is a constitutive energy-demanding organ. Glucose and long chain FFA are major substrates 
in cardiac tissue although it is highly flexible and able to use other substrates when available, 
this metabolic plasticity being key to normal cardiac physiology. Notably, increased long 
chain FFA supply to cardiomyocytes, as found during obesity, will evoke persistent 
localization of its transporter CD36 in the sarcolemma, thus leading to chronically elevated 
long chain FFA uptake and lipid accumulation what finally results in IR (Muoio, 2014). This 
IR further prevents the cardiac metabolic flexibility required to supply the vast amounts of 
ATP needed for continuous cardiac contraction. Moreover, abundant evidence shows that 
obesity-related disorders are associated with structural and functional changes in the heart 
both in humans and in animal models. In fact, heart failure and overt cardiovascular disease is 
the leading cause of death worldwide  and obesity and its related comorbidities are well-
established risk factors considered to dramatically increase their incidence (Dzau, 2006). 
Under unhealthy lifestyle habits, the heart undergoes initially compensatory changes that, 
when maintained, finally initiate heart failure. The main features of obesity-related cardiac 
remodelling are an increase in total blood volume and thus increased cardiac output, left 
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ventricular hypertrophy, left ventricular systolic and diastolic dysfunction, and fat 
accumulation (Abel, 2008). The aetiology of cardiac hypertrophy is complex and may have as 
underlying triggers the expansion of plasma volume and the activation of the sympathetic 
nervous system. While left ventricular hypertrophy is regarded as the main characteristic of 
obesity-induced cardiac remodelling both in humans and animal models (Abel, 2008), other 
emerging features such as accumulation of intramyocelullar triglycerides in the heart also 
appear to be important. Intra-myocyte fat accumulation has been reported in ob/ob and db/db 
mice (Buchanan, 2005), Zucker obese rats (Olsen, 2013) and following HFD (Torre-
Villalvazo, 2009). This cardiac steatosis has been related with increased levels of ceramides 
and cardiomyocyte apoptosis (Zhou, 2000, van de Weijer, 2011) leading to lipotoxic 
cardiomyopathy. However, lipid accumulation in the myocardium is not necessary damaging 
as it could be a marker of the adaptation of the heart upon disproportionate dietary fat and/or 
cardiac IR thereby helping avoid an excessive flux towards mitochondrial oxidative 
phosphorylation and ROS production. In any case, this intramyocardial lipid accumulation 
has been reported to alter cardiac functionality in obese animal models, with mild impaired 
diastolic function in adult animals in the absence or presence of mild systolic dysfunction 
(Christoffersen, 2003). Moreover in some cases interstitial (Zhou, 2000) or perivascular 
fibrosis (Zaman, 2004) have been reported in some animal models of obesity.  
Molecular keys in the heart 
At a molecular level, the mechanisms that contribute to structural and functional changes in 
the heart of obese animals are: impaired insulin signalling and changes in cardiac metabolism 
(characteristic of diabetic cardiomyopathy), mitochondrial dysfunction and oxidative stress, 
neurohumoral activation and volume/pressure overload, inflammation, fibrosis and apoptosis 
(Abel, 2008). Two main signalling pathways are involved in cardiac remodelling and 
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dysfunction: the insulin and the renin-angiotensin systems. In fact, inhibition of negative 
modulators of the insulin signalling pathway such as PTP1B (Kandadi, 2014) or the use of 
inhibitors of the angiotensin-converting enzyme (Duarte, 1999, Nevelsteen, 2013) or the use 
of antagonists of the angiotensin II receptor (Oliveira Junior, 2013) restore, at least in part, 
obesity-induced alterations in cardiac tissue.  
Interestingly, GRK2 is a negative modulator of both insulin and angiotensin II pathways 
(Mayor, 2011, Lucas, 2014b, Avendano, 2014). In fact, GRK2 is a key player in the crosstalk 
between insulin receptor signalling and other GPCRs critical for cardiac contractility and 
physiology, such as the β-adrenergic receptors (β-AR). Indeed, its inhibition or genetic 
deletion in several animal models of HF has shown that GRK2 targeting improves different 
parameters of the failing heart (reviewed in (Sato, 2015, Cannavo, 2013). Along the same 
line, paroxetine, which selectively inhibits GRK2 (Homan and Tesmer, 2015), has been 
recently reported to block or even reverse heart damage after myocardial infarction in a 
mouse model (Schumacher, 2015). In addition, non-βAR properties of GRK2 appear to also 
contribute to its pathological effects. In this regard, GRK2 also desensitizes adiponectin 
receptor 1 in failing cardiomyocytes, contributing to and HF progression (Wang, 2015). Thus, 
its inhibition will likely complement existing therapies such as βAR blockade.  
At the molecular level, it has been suggested that increased GRK2 levels upon chronic β-AR 
stimulation can directly interact and phosphorylate IRS1 and underlie the excessive 
sympathetic nervous system activity-triggered IR in HEK-293 cells (Cipolletta, 2009). A 
similar mechanism occurs in cardiomyocytes and has been related to the pathogenesis of the 
injured heart (Ciccarelli, 2011). On the other hand, it was shown that insulin can promote β2-
AR phosphorylation directly impairing β-AR-regulated cardiac contractility. The insulin-
induced phosphorylation of the β-AR seems to be dependent on IRS1 and IRS2 and involve 
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PKA and GRK2 activity (Fu, 2014). So, GRK2 would link cardiac remodelling and IR to 
impaired contractility and cardiac dysfunction, features that are present in obese individuals 
and may lead to heart failure. In fact, our group has recently described that the levels of 
GRK2 are increased in the cardiac tissue of ob/ob mice and after HFD feeding (Lucas, 
2014b). On the contrary, exercise, which is critical for the prevention and treatment of obesity 
and has been described to reduce IR in cardiac muscle of HFD-fed rats (Medeiros, 2011), is 
able to decrease myocardial GRK2 levels (MacDonnell, 2005) highlighting the 
cardioprotective role of lowering GRK2 levels for the obese heart.  Moreover, unpublished 
results from our and other groups suggest that lower levels of GRK2 protect the heart from 
obesity-induced cardiac remodelling (Lucas E, in preparation). Altogether, our findings 
suggest that pathological inputs of different aetiology such as increased catecholamine levels 
or high dietary fat converge in common important nodes. One such key connecting hub is 
GRK2 whose enhanced cardiac expression would be responsible for fuelling dysfunctionality 
both in the GPCR and insulin signalling cascades, thus allowing progression towards 
maladaptive remodelling  (Lucas, 2014a).  
 
Vasculature 
Obesity also has a key impact on vascular function, structure and on the mechanical 
properties of the vessels by several important means: it decreases endothelium-dependent 
vasodilation, increases intima-media ratio and vascular media thickness and enhances vessel 
stiffness (Briones, 2014, Prieto, 2014). These vascular alterations might impair tissue 
perfusion and contribute to the damage in different target organs observed in this pathology 
(Briones, 2014, Prieto, 2014). Mechanisms responsible for the vascular alterations associated 
to obesity include indirect phenomena associated to IR and also the presence of concomitant 
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risk factors such as hypertension, diabetes or dyslipidaemia as well as direct mechanisms 
associated with effects of adipokines, FFA and inflammation on the vascular wall (Briones, 
2014, Prieto, 2014).  
Molecular keys in the vasculature 
Particularly important mediators in the vascular dysfunction associated to obesity are 
effectors of the renin-angiotensin-aldosterone system such as AngII and aldosterone, but also 
endothelin and prostanoids that can signal through specific GPCRs (Briones, 2014, Prieto, 
2014, Even, 2014). These mediators stimulate vascular smooth muscle cells (VSMC) 
proliferation or migration, change extracellular matrix deposition, and counteract the 
vasodilator actions of nitric oxide (NO) through different mechanisms including increased 
ROS that reduce NO bioavailability. NO deficiency during obesity can also be ascribed to 
altered expression/activity of the endothelial NO synthase (eNOS) or eNOS uncoupling due to 
substrate or cofactor deficiency (Briones, 2014, Prieto, 2014, Miao and Li, 2012, Iantorno, 
2014, Paneni, 2013). In addition, recent evidences demonstrate that the diminished NO 
production in obesity is triggered by alterations in eNOS activation through the 
phosphorylation at Ser1177 by different kinases (Mount, 2007, Prieto, 2014). More 
specifically, defective eNOS phosphorylation and NO production by the PI3K/AKT pathway 
have been described in obesity in response to different stimuli including insulin (reviewed in 
(Prieto, 2014)). In this regard, IR in endothelial cells impairs the production of NO, favours 
the production of endothelin-1 though the MAPK axis and thus the vasoconstrictive and 
mitogenic responses on the vascular wall (Muniyappa and Quon, 2007) leading to endothelial 
dysfunction.  
Earlier studies demonstrated that AKT physically interacts with GRK2 and this interaction 
inhibits AKT activity and NO production (Liu, 2005). In addition, different mediators 
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involved in vascular damage in obesity/diabetes upregulate GRK2 expression. Thus, the 
increased GRK2 expression observed in vessels from diabetic mice (Taguchi, 2011a, Taguchi, 
2011b, Taguchi, 2012a, Taguchi, 2012b) is abolished by AngII type I receptor blockade 
(Taguchi, 2011b) suggesting that AngII increases GRK2 expression as confirmed recently by 
our group (Avendano, 2014). Moreover, in cultured endothelial cells high glucose/high 
insulin milieu upregulates GRK2 by an still unknown mechanism leading to inhibition of the 
insulin/AKT/eNOS pathway (Taguchi, 2014). In diabetes, the increased levels of GRK2 seem 
to prevent the translocation of β-arrestin2 to the membrane which acts as a scaffold molecule 
for AKT to the insulin receptor (Luan, 2009), thereby contributing to impaired 
AKT/eNOS/NO production in response to insulin and other agonists (Taguchi, 2011a, 
Taguchi, 2012a, Taguchi, 2012b, Taguchi, 2014). More importantly, GRK2 inhibition or 
partial GRK2 deletion improved the endothelial dysfunction observed in obese/diabetic 
(Taguchi, 2011b, Taguchi, 2012b, Taguchi, 2013) or hypertensive (Avendano, 2014) animal 
models by restoring the impaired AKT/eNOS pathway and NO availability.  
Vessels from obese patients or animal models of obesity generally display hypertrophic 
remodelling  with particular differences depending of the vascular bed (Briones, 2014). This 
vascular remodelling  seems to be influenced by hemodynamic factors such as hypertension 
and also by metabolic factors such as insulin or adipokines and it is partially reversed by 
pharmacological blockade of different components of the renin- angiotensin-aldosterone or 
endothelin systems (Briones, 2014). To date, the role of GRK2 in the structural and 
mechanical alterations observed in obesity is unknown, however, partial GRK2 deletion 
prevented vascular hypertrophy and increased vessel stiffness induced by AngII (Avendano, 
2014), suggesting that GRK2 might have a key role in vascular alterations in obesity-
associated hypertension. The mechanisms responsible of these vascular effects of GRK2 in 
vivo are unknown, and in vitro studies have revealed conflicting results. Thus, GRK2 and 
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arrestin seem to be essential for agonist-stimulated VSMC migration through different 
mechanisms including activation of proliferative and promigratory MAPK such as ERK1/2 
(Morris, 2012). However, a protective role for GRK2 in VSMC proliferation has also been 
shown (Peppel, 2000, Guo, 2009). In sum the results presented in this section suggest that 
GRK2 is a newly identified key contributor of the endothelial dysfunction and other vascular 
alterations observed during obesity. 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
Given the multi-organ effects of insulin and the key role for the integration of these tissue-
specific effects, it becomes crucial to understand how this physiopathological network 
operates in order to globally explain the outcomes of obesity and IR (Figure 1). 
In this review we put together the different outcomes of fat accumulation and IR in the main 
insulin-responsive tissues, highlighting the role of the most important molecular routes that 
participate in the control of disease progression both in an organ-specific and also in a more 
systemic manner (Figure 2). We believe that a multi-organ approach to the study of the onset 
and progression of the insulin-resistant and obese condition is, currently, the most valid 
approximation if we aim to understand in depth the different pathophysiological outcomes 
and the distinct molecular basis of the disease. In particular, this type of approach becomes 
essential if we intend to interpret the consequences of our experimental findings in a 
particular cell type in a more global whole body context. From the analysis of cell line and 
tissue-specific studies, important molecular mechanisms are identified and its cellular 
consequences can be described, but they will only be validated if introduced into a more 
Page 33 of 60
URL: http://mc.manuscriptcentral.com/napb  Email: eckel@uni-duesseldorf.de
Archives Of Physiology And Biochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 33
complex picture including a network of inter-organ communication and regulatory activities 
that help explain the final outcomes observed in the obese condition.  
We believe that certain signalling nodes, in particular those having specific roles in different 
organs and cell types such as PTP1B, PTEN or GRK2 among others (Figure 2), are bound to 
emerge as key pharmacological targets given the fact that they can more actively help 
integrate the response of different tissues and efficiently fight the pathological consequences 
of obesity and insulin resistance in a multi-organ manner. 
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FIGURE LEGENDS 
Figure 1. Physiological roles of the different insulin-target tissues and integration of the 
multi-organ effects of obesity in the physiopathology of insulin resistance. In healthy 
individuals, insulin-target tissues function coordinately in order to finely tune metabolism and 
energy homeostasis. During obesity, the specific deregulation of each tissue contributes to the 
progress of the complex pathological scenario observed in the obese, including the 
development of a low grade chronic inflammatory state and the appearance of insulin 
resistance in a systemic manner. Moreover, when the fat storage capacity in the adipose tissue 
is surpassed, fat is accumulated in other organs, boosting tissue inflammation, shifting 
substrate utilization and altering endocrine function, further contributing to the systemic 
insulin resistance and subsequent metabolic deregulation. 
Figure 2. Key molecular nodes regulating insulin signalling and resistance. Insulin 
activates the insulin receptor (IR), which phosphorylates and recruits different substrate 
adaptors such as the IRS protein family. Tyrosine-phosphorylated IRS proteins act then as 
scaffolds coupling IR stimulation to the activation of the phosphatidylinositol 3-kinase 
(PI3K), which has a major role in insulin function, mainly via the activation of AKT, which 
phosphorylates many cellular proteins, thus regulating several processes that lead to the 
control of physiopathological effects in different organs and tissues. Insulin signalling is 
controlled by negative modulators that tightly control the biological response to this hormone 
and act at different stages of the transduction cascade. Pathological alterations in any of these 
modulators, as observed during obesity or inflammation, may lead to the development of IR. 
These signalling nodes, in particular those having specific roles in different organs and at 
various levels, such as JNK and IKK as well as mTORC1, PTP1B, PTEN or GRK2 emerge as 
key potential pharmacological targets. 
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Figure 1. Physiological roles of the different insulin-target tissues and integration of the multi-organ effects 
of obesity in the physiopathology of insulin resistance. In healthy individuals, insulin-target tissues function 
coordinately in order to finely tune metabolism and energy homeostasis. During obesity, the specific 
deregulation of each tissue contributes to the progress of the complex pathological scenario observed in the 
obese, including the development of a low grade chronic inflammatory state and the appearance of insulin 
resistance in a systemic manner. Moreover, when the fat storage capacity in the adipose tissue is surpassed, 
fat is accumulated in other organs, boosting tissue inflammation, shifting substrate utilization and altering 
endocrine function, further contributing to the systemic insulin resistance and subsequent metabolic 
deregulation.  
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Figure 2. Key molecular nodes regulating insulin signalling and resistance. Insulin activates the insulin 
receptor (IR), which phosphorylates and recruits different substrate adaptors such as the IRS protein family. 
Tyrosine-phosphorylated IRS proteins act then as scaffolds coupling IR stimulation to the activation of the 
phosphatidylinositol 3-kinase (PI3K), which has a major role in insulin function, mainly via the activation of 
AKT, which phosphorylates many cellular proteins, thus regulating several processes that lead to the control 
of physiopathological effects in different organs and tissues. Insulin signalling is controlled by negative 
modulators that tightly control the biological response to this hormone and act at different stages of the 
transduction cascade. Pathological alterations in any of these modulators, as observed during obesity or 
inflammation, may lead to the development of IR. These signalling nodes, in particular those having specific 
roles in different organs and at various levels, such as JNK and IKK as well as mTORC1, PTP1B, PTEN or 
GRK2 emerge as key potential pharmacological targets.  
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